{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:45:24Z","timestamp":1779399924307,"version":"3.53.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s40263-023-01012-9","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T17:01:36Z","timestamp":1686243696000},"page":"523-529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clonazepam Loading Dose in Status Epilepticus: Is More Always Better?"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8180-4590","authenticated-orcid":false,"given":"Jennifer","family":"D\u2019Anto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Beuchat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea O.","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Novy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"issue":"10","key":"1012_CR1","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/S1474-4422(11)70187-9","volume":"10","author":"AO Rossetti","year":"2011","unstructured":"Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011;10(10):922\u201330.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1012_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S1474-4422(15)00296-3","volume":"15","author":"V Navarro","year":"2016","unstructured":"Navarro V, Dagron C, Elie C, Lamhaut L, Demeret S, Urien S, et al. Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial. Lancet Neurol. 2016;15(1):47\u201355.","journal-title":"Lancet Neurol"},{"issue":"13","key":"1012_CR3","doi-asserted-by":"publisher","first-page":"e1393","DOI":"10.1212\/WNL.0000000000200912","volume":"99","author":"SA Choi","year":"2022","unstructured":"Choi SA, Lee H, Kim K, Park SM, Moon HJ, Koo YS, et al. Mortality, disability, and prognostic factors of status epilepticus: a nationwide population-based retrospective cohort study. Neurology. 2022;99(13):e1393\u2013401.","journal-title":"Neurology"},{"issue":"7","key":"1012_CR4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJMoa1107494","volume":"366","author":"R Silbergleit","year":"2012","unstructured":"Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366(7):591\u2013600.","journal-title":"N Engl J Med"},{"issue":"11","key":"1012_CR5","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1001\/jama.1983.03330350028021","volume":"249","author":"IE Leppik","year":"1983","unstructured":"Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA. 1983;249(11):1452\u20134.","journal-title":"JAMA"},{"key":"1012_CR6","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1056\/NEJM199809173391202","volume":"339","author":"D Treiman","year":"1998","unstructured":"Treiman D, Meyers P, Walton N, Collins JF, Colling CMM. A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med. 1998;339:792\u20138.","journal-title":"N Engl J Med"},{"issue":"9","key":"1012_CR7","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s40263-022-00940-2","volume":"36","author":"R Kienitz","year":"2022","unstructured":"Kienitz R, Kay L, Beuchat I, Gelhard S, von Brauchitsch S, Mann C, et al. Benzodiazepines in the management of seizures and status epilepticus: a review of routes of delivery, pharmacokinetics, efficacy, and tolerability. CNS Drugs. 2022;36(9):951\u201375.","journal-title":"CNS Drugs"},{"issue":"8","key":"1012_CR8","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/epi.13056","volume":"56","author":"V Alvarez","year":"2015","unstructured":"Alvarez V, Lee JW, Drislane FW, Westover MB, Novy J, Dworetzky BA, et al. Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: a multicenter comparison. Epilepsia. 2015;56(8):1275\u201385.","journal-title":"Epilepsia"},{"issue":"3","key":"1012_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/epi.16825","volume":"62","author":"AG Sathe","year":"2021","unstructured":"Sathe AG, Underwood E, Coles LD, Elm JJ, Silbergleit R, Chamberlain JM, et al. Patterns of benzodiazepine underdosing in the established status epilepticus treatment trial. Epilepsia. 2021;62(3):795\u2013806.","journal-title":"Epilepsia"},{"key":"1012_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1017\/CBO9780511526930","volume-title":"Status epilepticus its clinical features and treatment in children and adults","author":"S Shorvon","year":"1994","unstructured":"Shorvon S. Status epilepticus its clinical features and treatment in children and adults. Cambridge University Press; 1994. p. 230\u20134."},{"issue":"5","key":"1012_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2165\/00003495-197612050-00001","volume":"12","author":"RM Pinder","year":"1976","unstructured":"Pinder RM, Brogden RN, Speight TM, Avery GS. Clonazepam: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs. 1976;12(5):321\u201361.","journal-title":"Drugs"},{"key":"1012_CR12","first-page":"60","volume":"53","author":"R Kruse","year":"1973","unstructured":"Kruse R, Blankenhorn V. Clinical use and effect of Ro 5\u20134023 (clonazepam) in different forms of epileptic seizures. Acta Neurol Scand Suppl. 1973;53:60\u201371.","journal-title":"Acta Neurol Scand Suppl"},{"issue":"14","key":"1012_CR13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.5694\/j.1326-5377.1973.tb110623.x","volume":"1","author":"PF Bladin","year":"1973","unstructured":"Bladin PF. The use of clonazepam as an anticonvulsant\u2013clinical evaluation. Med J Aust. 1973;1(14):683\u20138.","journal-title":"Med J Aust"},{"issue":"3","key":"1012_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/s-0028-1091744","volume":"4","author":"D Martin","year":"1973","unstructured":"Martin D, Hirt HR. Clinical experience with clonazepam (Rivotril) in the treatment of epilepsies in infancy and childhood. Neuropadiatrie. 1973;4(3):245\u201366.","journal-title":"Neuropadiatrie"},{"issue":"3","key":"1012_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1528-1157.1971.tb04928.x","volume":"12","author":"H Gastaut","year":"1971","unstructured":"Gastaut H, Courjon J, Poir\u00e9 R, Weber M. Treatment of status epilepticus with a new benzodiazepine more active than diazepam. Epilepsia. 1971;12(3):197\u2013214.","journal-title":"Epilepsia"},{"issue":"3","key":"1012_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","volume":"17","author":"H Meierkord","year":"2010","unstructured":"Meierkord H, Boon P, Engelsen B, G\u00f6cke K, Shorvon S, Tinuper P, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2010;17(3):348\u201355.","journal-title":"Eur J Neurol"},{"issue":"10","key":"1012_CR17","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1007\/s00115-020-01036-2","volume":"92","author":"F Rosenow","year":"2021","unstructured":"Rosenow F, Weber J. S2k guidelines: status epilepticus in adulthood: guidelines of the German Society for Neurology. Nervenarzt. 2021;92(10):1002\u201330.","journal-title":"Nervenarzt"},{"issue":"2","key":"1012_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1528-1167.2009.02323.x","volume":"51","author":"J Novy","year":"2010","unstructured":"Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia. 2010;51(2):251\u20136.","journal-title":"Epilepsia"},{"key":"1012_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.yebeh.2015.05.007","volume":"49","author":"M Leitinger","year":"2015","unstructured":"Leitinger M, Beniczky S, Rohracher A, Gardella E, Kalss G, Qerama E, et al. Salzburg consensus criteria for non-convulsive status epilepticus\u2013approach to clinical application. Epilepsy Behav. 2015;49:158\u201363.","journal-title":"Epilepsy Behav"},{"issue":"5","key":"1012_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/jnnp.2005.080887","volume":"77","author":"AO Rossetti","year":"2006","unstructured":"Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB. Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry. 2006;77(5):611\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"20","key":"1012_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13054-016-1190-z","volume":"27","author":"BS Kang","year":"2016","unstructured":"Kang BS, Kim DW, Kim KK, Moon HJ, Kim YS, Kim HK, et al. Prediction of mortality and functional outcome from status epilepticus and independent external validation of STESS and EMSE scores. Crit Care. 2016;27(20):25.","journal-title":"Crit Care"},{"issue":"10","key":"1012_CR22","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00415-008-0989-1","volume":"255","author":"AO Rossetti","year":"2008","unstructured":"Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB. Status epilepticus severity score (STESS): a tool to orient early treatment strategy. J Neurol. 2008;255(10):1561\u20136.","journal-title":"J Neurol"},{"issue":"12","key":"1012_CR23","doi-asserted-by":"publisher","first-page":"e475","DOI":"10.1097\/CCM.0b013e31829eca06","volume":"41","author":"R Sutter","year":"2013","unstructured":"Sutter R, Kaplan PW, R\u00fcegg S. Independent external validation of the status epilepticus severity score. Crit Care Med. 2013;41(12):e475\u20139.","journal-title":"Crit Care Med"},{"issue":"4","key":"1012_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1684\/epd.2014.0709","volume":"16","author":"S Cheng","year":"2014","unstructured":"Cheng S. Non-convulsive status epilepticus in the elderly. Epileptic Disord. 2014;16(4):385\u201394.","journal-title":"Epileptic Disord"},{"key":"1012_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.seizure.2021.11.004","volume":"94","author":"GM Tedrus","year":"2022","unstructured":"Tedrus GM, Nogueira EJ, Vidal MA. Elderly patients with nonconvulsive status epilepticus: clinical-EEG data, hospital mortality, STESS and EMSE. Seizure. 2022;94:18\u201322.","journal-title":"Seizure"},{"issue":"6","key":"1012_CR26","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/j.1528-1167.2008.01993.x","volume":"50","author":"FW Drislane","year":"2009","unstructured":"Drislane FW, Blum AS, Lopez MR, Gautam S, Schomer DL. Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia. 2009;50(6):1566\u201371.","journal-title":"Epilepsia"},{"key":"1012_CR27","first-page":"107","volume":"7","author":"K Sithamparanathan","year":"2012","unstructured":"Sithamparanathan K, Sadera A. Adverse effects of benzodiazepine use in elderly people: a meta-analysis. Asian J Gerontol Geriatr. 2012;7:107\u201311.","journal-title":"Asian J Gerontol Geriatr"},{"issue":"11","key":"1012_CR28","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.mayocp.2016.07.024","volume":"91","author":"M Markota","year":"2016","unstructured":"Markota M, Rummans TA, Bostwick JM, Lapid MI. Benzodiazepine use in older adults: dangers, management, and alternative therapies. Mayo Clin Proc. 2016;91(11):1632\u20139.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"1012_CR29","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1517\/14740338.3.5.485","volume":"3","author":"S Madhusoodanan","year":"2004","unstructured":"Madhusoodanan S, Bogunovic OJ. Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf. 2004;3(5):485\u201393.","journal-title":"Expert Opin Drug Saf"},{"issue":"8","key":"1012_CR30","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1111\/epi.12235","volume":"54","author":"M Spatola","year":"2013","unstructured":"Spatola M, Alvarez V, Rossetti AO. Benzodiazepine overtreatment in status epilepticus is related to higher need of intubation and longer hospitalization. Epilepsia. 2013;54(8):e99\u2013102.","journal-title":"Epilepsia"},{"issue":"6","key":"1012_CR31","doi-asserted-by":"publisher","first-page":"e564","DOI":"10.1212\/WNL.0000000000012292","volume":"97","author":"P De Stefano","year":"2021","unstructured":"De Stefano P, Baumann SM, Semmlack S, R\u00fcegg S, Marsch S, Seeck M, et al. Safety and efficacy of coma induction following first-line treatment in status epilepticus: a 2-center study. Neurology. 2021;97(6):e564\u201376.","journal-title":"Neurology"},{"issue":"15","key":"1012_CR32","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1001\/jama.2017.13889","volume":"318","author":"B Guidet","year":"2017","unstructured":"Guidet B, Leblanc G, Simon T, Woimant M, Quenot JP, Ganansia O, et al. Effect of systematic intensive care unit triage on long-term mortality among critically ill elderly patients in france: a randomized clinical trial. JAMA. 2017;318(15):1450\u20139.","journal-title":"JAMA"},{"issue":"7","key":"1012_CR33","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/j.1528-1167.2011.03056.x","volume":"52","author":"V Alvarez","year":"2011","unstructured":"Alvarez V, Januel JM, Burnand B, Rossetti AO. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia. 2011;52(7):1292\u20136.","journal-title":"Epilepsia"},{"issue":"3","key":"1012_CR34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ana.25416","volume":"85","author":"C Kellinghaus","year":"2019","unstructured":"Kellinghaus C, Rossetti AO, Trinka E, Lang N, May TW, Unterberger I, et al. Factors predicting cessation of status epilepticus in clinical practice: data from a prospective observational registry (SENSE). Ann Neurol. 2019;85(3):421\u201332.","journal-title":"Ann Neurol"},{"key":"1012_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ajem.2021.01.094","volume":"44","author":"KA Weant","year":"2021","unstructured":"Weant KA, Barr\u00e9 SL, Bruner S, Smiley R, Hall GA. Assessment of benzodiazepine dosing strategies for the management of status epilepticus in the emergency department. Am J Emerg Med. 2021;44:106\u201311.","journal-title":"Am J Emerg Med"},{"issue":"2","key":"1012_CR36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00415-012-6644-x","volume":"260","author":"AO Rossetti","year":"2013","unstructured":"Rossetti AO, Alvarez V, Januel JM, Burnand B. Treatment deviating from guidelines does not influence status epilepticus prognosis. J Neurol. 2013;260(2):421\u20138.","journal-title":"J Neurol"},{"issue":"6","key":"1012_CR37","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1111\/epi.16534","volume":"61","author":"AG Sathe","year":"2020","unstructured":"Sathe AG, Elm JJ, Cloyd JC, Chamberlain JM, Silbergleit R, Kapur J, et al. The association of patient weight and dose of fosphenytoin, levetiracetam, and valproic acid with treatment success in status epilepticus. Epilepsia. 2020;61(6):e66\u201370.","journal-title":"Epilepsia"},{"issue":"9","key":"1012_CR38","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1111\/ene.15441","volume":"29","author":"S Vijiala","year":"2022","unstructured":"Vijiala S, Andr\u00e9 P, Buclin T, Decosterd LA, Rossetti AO, Novy J. Valproate in status epilepticus: correlation between loading dose, serum levels, and clinical response. Eur J Neurol. 2022;29(9):2607\u201311.","journal-title":"Eur J Neurol"},{"key":"1012_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.yebeh.2017.03.031","volume":"74","author":"J D'Anto","year":"2017","unstructured":"D\u2019Anto J, Wnuk W, Rossetti AO, Decosterd LA, Buclin T, Novy J. Lamotrigine serum levels: ceiling effect in people with epilepsy in remission? Epilepsy Behav. 2017;74:41\u20134.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"1012_CR40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/ane.13450","volume":"144","author":"I A\u00edcua-Rap\u00fan","year":"2021","unstructured":"A\u00edcua-Rap\u00fan I, Andr\u00e9 P, Rossetti AO, D\u00e9costerd LA, Buclin T, Novy J. Seizure freedom and plasma levels of newer generation antiseizure medications. Acta Neurol Scand. 2021;144(2):202\u20138.","journal-title":"Acta Neurol Scand"},{"key":"1012_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/epi.14607","volume":"60","author":"M Leitinger","year":"2019","unstructured":"Leitinger M, Trinka E, Giovannini G, Zimmermann G, Florea C, Rohracher A, et al. Epidemiology of status epilepticus in adults: a population-based study on incidence, causes, and outcomes. Epilepsia. 2019;60:53\u201362.","journal-title":"Epilepsia"},{"issue":"22","key":"1012_CR42","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","volume":"381","author":"J Kapur","year":"2019","unstructured":"Kapur J, Elm J, Chamberlain JM, Barsan W, Cloyd J, Lowenstein D, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;381(22):2103\u201313.","journal-title":"N Engl J Med"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-023-01012-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-023-01012-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-023-01012-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T21:21:07Z","timestamp":1702588867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-023-01012-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s40263-023-01012-9","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"11 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study did not receive specific funding. Open access funding provided by University of Lausanne.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The registry used in the study was approved by our local ethics committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Need for a specific consent was waived as the study only analyzed anonymized data. General consent for use of all clinical data for research is a standard procedure in our hospital. Patients that explicitly refused the use of all their data for research purposes were excluded.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Anonymized data not published within this article will be made available by request from any qualified investigator.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"JN\/AOR had the idea of the article. JN, JDA, IB reviewed the literature. JN, JDA analysed the data and drafted the work. IB and AOR critically revised the work. All authors read the article and approved the final version, they agree to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}